AGP Executive Report
Last update: 8 hours agoHIV Prevention Rollout: Cameroon has started a pilot of CAB-PrEP, a long-acting injectable HIV prevention drug (cabotegravir) given every two months, with officials saying it’s up to 95% effective and will begin in high-transmission areas starting with Douala. Public Health Progress: The same period reports Cameroon has met two of the UN “95-95-95” HIV targets—96.4% of diagnosed people on treatment and 95% achieving viral suppression—while only 77.1% know their status. Maternal Health Case Report: A case report highlights Purple Urine Bag Syndrome (PUBS) in a 26-year-old woman living with HIV, describing the rare catheter-related purple urine discoloration and its clinical context. Disaster Response in Douala: Douala authorities are assessing a partially collapsed three-story building in Bonamoussadi after heavy rains, reporting at least six deaths (including three children) and six injuries, with engineers checking nearby structures for secondary risks. HIV Hotspot Update: New findings from Cameroon’s HIV impact assessment flag the Northwest Region as a hotspot (5.6% prevalence), underscoring uneven progress across regions. Community Health & Safety: Grassroots women in the Northwest and Southwest are mobilizing against youth drug abuse and gender-based violence, including a large advocacy walk after a reported rape case.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
